Literature DB >> 2106751

Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.

K Koretz1, P Schlag, P Möller.   

Abstract

Using the monoclonal antibody EGF-R1, the expression of epidermal growth factor receptor (EGFR) was investigated immunohistochemically in normal colonic mucosa distant from and adjacent to colonic neoplasms, in 25 adenomas and in 144 unselected colorectal carcinomas. EGFR expression was an inconsistent phenomenon in each of these conditions. It was not expressed in 23/44 non-neoplastic mucosa specimens distant from and in 26/44 mucosae adjacent to colon tumours; 15/25 adenomas and 71 (49.3%) of the carcinomas failed to contain detectable amounts of EGFR. In contrast, large amounts of EGFR were found in 4 non-neoplastic mucosae at both locations, in 3 adenomas and in 11 (7.6%) carcinomas. The remaining cases showed complex patterns of EGFR-expression. In comparing mucosae close to and distant from a colonic tumour, only minor differences in EGFR content were observed. The intra-individual comparison of the mode of EGFR expression in non-neoplastic and neoplastic epithelium revealed an overexpression of EGFR in carcinomas in about one third of the 44 cases examined. One third showed no obvious differences, and one third showed lower levels of EGFR expression within the tumour. We conclude that the mode of EGFR expression in normal and neoplastic colon epithelium is variable and reflective of inter-individual constitutive differences rather than of abnormalities in gene regulation. Statistical analysis failed to reveal correlations between the mode of EGFR expression and tumour grade, type or Dukes stage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106751     DOI: 10.1007/bf01605295

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  43 in total

1.  Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.

Authors:  J R Glenney; W S Chen; C S Lazar; G M Walton; L M Zokas; M G Rosenfeld; G N Gill
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

2.  Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium.

Authors:  M I Wahl; S Nishibe; P G Suh; S G Rhee; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

3.  Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system.

Authors:  G Reifenberger; R Prior; M Deckert; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas.

Authors:  E Rothbauer; K Mann; B Wiebecke; P Borlinghaus; R Lamerz; E Pratschke; H J Krämling; A Pfeiffer
Journal:  Klin Wochenschr       Date:  1989-05-15

5.  The effect of epidermal growth factor (EGF) on cell proliferation of the gastrointestinal mucosa in rodents.

Authors:  A I Al-Nafussi; N A Wright
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1982

6.  Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues.

Authors:  L B Rall; J Scott; G I Bell; R J Crawford; J D Penschow; H D Niall; J P Coghlan
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

7.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

8.  Evidence for increased epidermal growth factor receptors in human sarcomas.

Authors:  B Gusterson; G Cowley; J McIlhinney; B Ozanne; C Fisher; B Reeves
Journal:  Int J Cancer       Date:  1985-12-15       Impact factor: 7.396

9.  Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma.

Authors:  K Sugiyama; Y Yonemura; I Miyazaki
Journal:  Cancer       Date:  1989-04-15       Impact factor: 6.860

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  16 in total

Review 1.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients.

Authors:  A Chowdhury; R Fukuda; S Fukumoto
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.

Authors:  Jayson Wang; James Hollingshead; Nabil El-Masry; Donna Horncastle; Ian Talbot; Ian Tomlinson; Malcolm R Alison; Mona El-Bahrawy
Journal:  J Gastrointest Cancer       Date:  2012-09

4.  Epidermal growth factor receptors in the oesophagus.

Authors:  J Jankowski; S Murphy; G Coghill; A Grant; K G Wormsley; D S Sanders; M Kerr; D Hopwood
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 5.  A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.

Authors:  Vanessa Deschoolmeester; Marc Baay; Pol Specenier; Filip Lardon; Jan B Vermorken
Journal:  Oncologist       Date:  2010-06-28

6.  Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.

Authors:  Evan S Glazer; Cihui Zhu; Katheryn L Massey; C Shea Thompson; Warna D Kaluarachchi; Amir N Hamir; Steven A Curley
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

7.  The relationship between mast cell infiltration and the expression of PCNA and EGFr in experimental hepatocellular carcinoma of liver and squamous cell carcinoma of stomach in rats.

Authors:  Y Ruan; Z Wu; S Ivankovic
Journal:  J Tongji Med Univ       Date:  1996

8.  Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.

Authors:  M Ramael; K Segers; C Buysse; J Van den Bossche; E Van Marck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

9.  Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma.

Authors:  Li Jiao; Liang Chen; Abeer Alsarraj; David Ramsey; Zhigang Duan; Hashem B El-Serag
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

10.  Immunoelectron microscopic localisation of transforming growth factor alpha in rat colon.

Authors:  R Pérez-Tomás; X Culleré; M Asbert; C Díaz-Ruiz
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.